(BSX) Stock Forecast, Price Target & Predictions
BSX Stock Forecast
stock forecast is as follows: an average price target of $95.50 (represents a 5.30% upside from BSX’s last price of $90.69) and a rating consensus of 'Buy', based on 16 wall street analysts offering a 1-year stock forecast.
BSX Price Target
BSX Analyst Ratings
Buy
Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Jan 02, 2025 | Vijay Kumar | Evercore ISI | $100.00 | $89.38 | 11.88% | 10.27% |
Dec 30, 2024 | Marie Thibault | BTIG | $101.00 | $89.68 | 12.62% | 11.37% |
Oct 24, 2024 | Shagun Singh | RBC Capital | $98.00 | $87.45 | 12.06% | 8.06% |
Oct 24, 2024 | Kristen Stewart | C.L. King | $90.00 | $87.45 | 2.92% | -0.76% |
Oct 21, 2024 | William Plovanic | Canaccord Genuity | $98.00 | $88.07 | 11.28% | 8.06% |
Oct 18, 2024 | Rick Wise | Stifel Nicolaus | $100.00 | $86.42 | 15.71% | 10.27% |
Oct 15, 2024 | David Rescott | Robert W. Baird | $100.00 | $87.55 | 14.22% | 10.27% |
Oct 14, 2024 | Richard Newitter | Truist Financial | $100.00 | $87.20 | 14.68% | 10.27% |
Sep 19, 2024 | Matt O'Brien | Piper Sandler | $90.00 | $84.22 | 6.86% | -0.76% |
Jul 25, 2024 | Pito Chickering | Deutsche Bank | $78.00 | $78.11 | -0.14% | -13.99% |
Jul 15, 2024 | Marie Thibault | BTIG | $84.00 | $77.69 | 8.12% | -7.38% |
Jun 18, 2024 | William Plovanic | Canaccord Genuity | $83.00 | $76.31 | 8.77% | -8.48% |
Jun 11, 2024 | David Rescott | Robert W. Baird | $90.00 | $77.42 | 16.25% | -0.76% |
May 30, 2024 | David Roman | Goldman Sachs | $90.00 | $74.98 | 20.03% | -0.76% |
May 28, 2024 | John Eade | Argus Research | $95.00 | $75.63 | 25.61% | 4.75% |
Apr 25, 2024 | Steven Lichtman | Oppenheimer | $77.00 | $73.27 | 5.09% | -15.10% |
Apr 25, 2024 | Vijay Kumar | Evercore ISI | $78.00 | $72.91 | 6.98% | -13.99% |
Apr 25, 2024 | Shagun Singh | RBC Capital | $82.00 | $72.91 | 12.47% | -9.58% |
Apr 25, 2024 | Anthony Petrone | Mizuho Securities | $85.00 | $72.91 | 16.58% | -6.27% |
Apr 25, 2024 | David Rescott | Robert W. Baird | $84.00 | $72.91 | 15.21% | -7.38% |
Apr 25, 2024 | Richard Newitter | Truist Financial | $86.00 | $72.91 | 17.95% | -5.17% |
Apr 25, 2024 | Lawrence Biegelsen | Wells Fargo | $82.00 | $72.91 | 12.47% | -9.58% |
Apr 24, 2024 | Pito Chickering | Deutsche Bank | $73.00 | $72.91 | 0.12% | -19.51% |
Apr 24, 2024 | Marie Thibault | BTIG | $80.00 | $72.91 | 9.72% | -11.79% |
Apr 24, 2024 | Rick Wise | Stifel Nicolaus | $83.00 | $72.91 | 13.84% | -8.48% |
Apr 15, 2024 | Marie Thibault | BTIG | $74.00 | $68.07 | 8.71% | -18.40% |
Apr 03, 2024 | John Eade | Argus Research | $80.00 | $67.45 | 18.61% | -11.79% |
Feb 01, 2024 | Anthony Petrone | Mizuho Securities | $80.00 | $64.82 | 23.42% | -11.79% |
Feb 02, 2023 | J.P. Morgan | $55.00 | $47.31 | 16.25% | -39.35% | |
Feb 02, 2023 | Needham | $53.00 | $47.54 | 11.49% | -41.56% | |
Jan 06, 2023 | Morgan Stanley | $56.00 | $46.18 | 21.26% | -38.25% | |
Dec 22, 2022 | Anthony Petrone | Mizuho Securities | $52.00 | $46.08 | 12.85% | -42.66% |
Dec 20, 2022 | Truist Financial | $54.00 | $45.64 | 18.32% | -40.46% | |
Dec 08, 2022 | Raymond James | $54.00 | $45.63 | 18.34% | -40.46% | |
Jul 28, 2022 | Raymond James | $48.00 | $40.83 | 17.56% | -47.07% | |
Jul 28, 2022 | BTIG | $50.00 | $40.31 | 24.04% | -44.87% | |
Jul 20, 2022 | Truist Financial | $45.00 | $37.44 | 20.19% | -50.38% | |
Jun 29, 2022 | Canaccord Genuity | $43.00 | $37.76 | 13.88% | -52.59% | |
Jun 24, 2022 | BTIG | $45.00 | $37.10 | 21.28% | -50.38% | |
Apr 30, 2022 | Matt O’Brien | Piper Sandler | $50.00 | $42.11 | 18.74% | -44.87% |
Apr 28, 2022 | Raymond James | $50.00 | $43.00 | 16.28% | -44.87% | |
Apr 28, 2022 | Leerink Partners | $48.00 | $43.06 | 11.47% | -47.07% | |
Mar 03, 2022 | Travis Steed | Bank of America Securities | $55.00 | $43.96 | 25.11% | -39.35% |
Feb 02, 2022 | Josh Jennings | Cowen & Co. | $50.00 | $41.44 | 20.66% | -44.87% |
Feb 02, 2022 | Marie Thibault | BTIG | $52.00 | $41.44 | 25.48% | -42.66% |
Dec 09, 2021 | Luke McFarlane | Macquarie | $51.00 | $41.28 | 23.55% | -43.76% |
Oct 28, 2021 | Brent Dilts | UBS | $118.00 | $43.24 | 172.90% | 30.11% |
Oct 28, 2021 | William Plovanic | Canaccord Genuity | $51.00 | $43.24 | 17.95% | -43.76% |
Oct 27, 2021 | Matthew O'Brien | Piper Sandler | $51.00 | $43.73 | 16.62% | -43.76% |
Sep 23, 2021 | Matt Miksic | Credit Suisse | $54.00 | $45.00 | 20.00% | -40.46% |
Sep 22, 2021 | Anthony Petrone | Jefferies | $55.00 | $44.31 | 24.13% | -39.35% |
Aug 02, 2021 | John Eade | Argus Research | $132.00 | $45.88 | 187.71% | 45.55% |
Aug 01, 2021 | Larry Biegelsen | Wells Fargo | $52.50 | $45.88 | 14.43% | -42.11% |
Jul 27, 2021 | Rick Wise | Stifel Nicolaus | $50.00 | $45.51 | 9.87% | -44.87% |
Jul 14, 2021 | Amit Hazan | Goldman Sachs | $50.00 | $42.74 | 16.99% | -44.87% |
Apr 29, 2021 | Chris Cooley | Stephens | $52.00 | $44.10 | 17.91% | -42.66% |
Apr 28, 2021 | Steven Lichtman | Oppenheimer | $47.00 | $44.24 | 6.24% | -48.18% |
Apr 28, 2021 | Joanne Wuensch | Citigroup | $51.00 | $44.24 | 15.28% | -43.76% |
Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | 2 | 8 | 28 |
Avg Price Target | $100.50 | $98.38 | $87.18 |
Last Closing Price | $90.69 | $90.69 | $90.69 |
Upside/Downside | 10.82% | 8.48% | -3.87% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Jan 02, 2025 | Evercore ISI | Outperform | Outperform | Hold |
Dec 30, 2024 | BTIG | Buy | Buy | Hold |
Dec 11, 2024 | Citigroup | Neutral | Neutral | Hold |
Dec 11, 2024 | Citigroup | Buy | Buy | Hold |
Oct 24, 2024 | Citigroup | Buy | Buy | Hold |
Oct 23, 2024 | BTIG | Buy | Buy | Hold |
Oct 21, 2024 | RBC Capital | Underperform | Underperform | Hold |
Oct 21, 2024 | William Blair | Buy | Buy | Hold |
Oct 21, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Oct 21, 2024 | Cowen & Co. | Buy | Buy | Hold |
Oct 21, 2024 | Canaccord Genuity | Buy | Buy | Hold |
Oct 18, 2024 | Needham | Buy | Hold | Downgrade |
Oct 14, 2024 | Raymond James | Underperform | Underperform | Hold |
Oct 14, 2024 | RBC Capital | Buy | Buy | Hold |
Oct 08, 2024 | RBC Capital | Outperform | Outperform | Hold |
Oct 01, 2024 | Evercore ISI | Outperform | Outperform | Hold |
Sep 27, 2024 | Cowen & Co. | Buy | Buy | Hold |
Sep 19, 2024 | Piper Sandler | Overweight | Overweight | Hold |
Sep 04, 2024 | Raymond James | Strong Buy | Strong Buy | Hold |
Aug 22, 2024 | Raymond James | Underperform | Underperform | Hold |
Aug 22, 2024 | RBC Capital | Buy | Buy | Hold |
Aug 22, 2024 | Citigroup | Buy | Buy | Hold |
Aug 22, 2024 | Barclays | Overweight | Overweight | Hold |
Jul 25, 2024 | Raymond James | Strong Buy | Strong Buy | Hold |
Jul 25, 2024 | Deutsche Bank | Hold | Hold | Hold |
Jul 16, 2024 | Cowen & Co. | Buy | Buy | Hold |
Jul 15, 2024 | UBS | Underperform | Underperform | Hold |
Jul 15, 2024 | Wells Fargo | Buy | Buy | Hold |
Jul 15, 2024 | Morgan Stanley | Overweight | Overweight | Hold |
Jul 15, 2024 | BTIG | Buy | Buy | Hold |
Jul 10, 2024 | Citigroup | Buy | Buy | Hold |
Jul 02, 2024 | Evercore ISI | Outperform | Outperform | Hold |
Jun 19, 2024 | Zacks Investment Research | Perform | Perform | Hold |
Jun 18, 2024 | Wells Fargo | Buy | Buy | Hold |
Jun 18, 2024 | Canaccord Genuity | Buy | Buy | Hold |
May 30, 2024 | Goldman Sachs | Buy | Initialise | |
May 22, 2024 | Citigroup | Buy | Buy | Hold |
May 20, 2024 | Cowen & Co. | Buy | Buy | Hold |
May 15, 2024 | Mizuho Securities | Buy | Buy | Hold |
Apr 26, 2024 | Barclays | Overweight | Overweight | Hold |
Apr 25, 2024 | Oppenheimer | Outperform | Outperform | Hold |
Apr 25, 2024 | Evercore ISI | Outperform | Outperform | Hold |
Apr 25, 2024 | RBC Capital | Underperform | Underperform | Hold |
Apr 25, 2024 | Wells Fargo | Buy | Buy | Hold |
Apr 25, 2024 | Citigroup | Buy | Buy | Hold |
Apr 25, 2024 | Wells Fargo | Overweight | Overweight | Hold |
Apr 24, 2024 | Deutsche Bank | Hold | Hold | Hold |
Apr 15, 2024 | RBC Capital | Outperform | Outperform | Hold |
Apr 15, 2024 | BTIG | Buy | Buy | Hold |
Apr 03, 2024 | Wells Fargo | Buy | Buy | Hold |
Apr 03, 2024 | Citigroup | Buy | Buy | Hold |
Mar 07, 2024 | RBC Capital | Underperform | Underperform | Hold |
Mar 07, 2024 | Wells Fargo | Buy | Buy | Hold |
Feb 01, 2024 | Needham | Buy | Buy | Hold |
Feb 01, 2024 | Mizuho Securities | Neutral | Buy | Upgrade |
Feb 01, 2024 | Wells Fargo | Buy | Buy | Hold |
Jan 16, 2024 | RBC Capital | Underperform | Underperform | Hold |
Jan 16, 2024 | Wells Fargo | Strong Buy | Strong Buy | Hold |
Dec 29, 2023 | Wells Fargo | Buy | Buy | Hold |
Dec 29, 2023 | Needham | Underperform | Underperform | Hold |
Sep 21, 2023 | Mizuho Securities | Neutral | Neutral | Hold |
Sep 21, 2023 | Needham | Buy | Buy | Hold |
Apr 27, 2023 | Morgan Stanley | Overweight | Overweight | Hold |
Feb 02, 2023 | Needham | Buy | Buy | Hold |
Jan 06, 2023 | Morgan Stanley | Overweight | Overweight | Hold |
Dec 08, 2022 | Raymond James | Strong Buy | Strong Buy | Hold |
Oct 26, 2022 | Piper Sandler | Overweight | Overweight | Hold |
Jul 28, 2022 | Raymond James | Strong Buy | Strong Buy | Hold |
Jul 28, 2022 | BTIG | Buy | Buy | Hold |
Jun 29, 2022 | Canaccord Genuity | Buy | Buy | Hold |
Jun 24, 2022 | BTIG | Buy | Buy | Hold |
May 27, 2022 | Needham | Buy | Upgrade | |
May 17, 2022 | Citigroup | Buy | Buy | Hold |
Apr 30, 2022 | Piper Sandler | Overweight | Overweight | Hold |
Apr 28, 2022 | Raymond James | Strong Buy | Strong Buy | Hold |
Apr 28, 2022 | SVB Leerink | Market Perform | Market Perform | Hold |
Financial Forecast
Revenue Forecast
Quarter
Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $3.39B | $3.24B | $3.17B | $3.24B | $3.03B | $3.13B | $2.93B | $3.08B | $2.75B | $2.71B | $2.66B |
Avg Forecast | $5.12B | $4.98B | $5.08B | $4.78B | $5.31B | $5.12B | $5.08B | $4.87B | $4.88B | $4.69B | $4.67B | $4.44B | $4.41B | $4.04B | $4.03B | $3.68B | $3.59B | $3.48B | $3.50B | $3.16B | $3.24B | $3.14B | $3.22B | $2.96B | $3.11B | $2.96B | $2.94B | $2.62B | $2.81B | $2.52B |
High Forecast | $5.30B | $5.15B | $5.25B | $4.94B | $5.50B | $5.29B | $5.26B | $5.04B | $5.05B | $4.85B | $4.83B | $4.60B | $4.48B | $4.04B | $4.03B | $3.68B | $3.61B | $3.53B | $3.62B | $3.26B | $3.34B | $3.14B | $3.22B | $2.96B | $3.11B | $2.96B | $2.94B | $2.62B | $2.81B | $2.52B |
Low Forecast | $4.94B | $4.81B | $4.90B | $4.61B | $5.13B | $4.94B | $4.91B | $4.70B | $4.71B | $4.53B | $4.50B | $4.30B | $4.35B | $4.04B | $4.03B | $3.68B | $3.56B | $3.44B | $3.38B | $3.04B | $3.15B | $3.14B | $3.22B | $2.96B | $3.11B | $2.96B | $2.94B | $2.62B | $2.81B | $2.52B |
# Analysts | 5 | 8 | 5 | 5 | 10 | 7 | 5 | 5 | 8 | 5 | 4 | 11 | 16 | 8 | 5 | 10 | 11 | 23 | 13 | 12 | 19 | 18 | 17 | 16 | 11 | 11 | 11 | 22 | 11 | 8 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.07% | 1.00% | 1.01% | 1.01% | 1.02% | 1.01% | 0.99% | 1.05% | 1.05% | 0.96% | 1.06% |
Forecast
EBITDA Forecast
Quarter
Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 5 | 8 | 5 | 5 | 10 | 7 | 5 | 5 | 8 | 5 | 4 | 11 | 16 | 8 | 5 | 10 | 11 | 23 | 13 | 12 | 19 | 18 | 17 | 16 | 11 | 11 | 11 | 22 | 11 | 8 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $744.00M | $659.00M | $578.00M | $693.00M | $708.00M | $498.00M | $841.00M | $498.00M | $675.00M | $402.00M | $-141.00M |
Avg Forecast | $1.05B | $1.02B | $1.04B | $982.43M | $1.09B | $1.05B | $1.05B | $1.00B | $1.00B | $965.51M | $960.55M | $913.26M | $908.13M | $831.37M | $828.91M | $764.72M | $739.28M | $715.36M | $720.62M | $695.20M | $535.35M | $683.20M | $699.92M | $632.00M | $677.05M | $644.32M | $639.79M | $544.35M | $611.98M | $548.43M |
High Forecast | $1.09B | $1.06B | $1.08B | $1.02B | $1.13B | $1.09B | $1.08B | $1.04B | $1.04B | $998.53M | $993.40M | $946.47M | $922.57M | $831.78M | $829.30M | $917.66M | $743.39M | $725.28M | $745.26M | $834.24M | $642.42M | $683.20M | $699.92M | $758.40M | $677.05M | $644.32M | $639.79M | $653.23M | $611.98M | $548.43M |
Low Forecast | $1.02B | $988.78M | $1.01B | $947.89M | $1.05B | $1.02B | $1.01B | $967.16M | $969.49M | $931.56M | $926.77M | $884.20M | $895.74M | $830.97M | $828.53M | $611.78M | $733.10M | $707.57M | $695.28M | $556.16M | $428.28M | $683.20M | $699.92M | $505.60M | $677.05M | $644.32M | $639.79M | $435.48M | $611.98M | $548.43M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.07% | 1.23% | 0.85% | 0.99% | 1.12% | 0.74% | 1.31% | 0.78% | 1.24% | 0.66% | -0.26% |
Forecast
Net Income Forecast
Quarter
Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 5 | 8 | 5 | 5 | 10 | 7 | 5 | 5 | 8 | 5 | 4 | 11 | 16 | 8 | 5 | 10 | 11 | 23 | 13 | 12 | 19 | 18 | 17 | 16 | 11 | 11 | 11 | 22 | 11 | 8 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $314.00M | $140.00M | $174.00M | $260.00M | $110.00M | $95.00M | $419.00M | $186.00M | $341.00M | $210.00M | $-155.00M |
Avg Forecast | $1.23B | $1.18B | $1.19B | $1.10B | $1.26B | $1.19B | $1.16B | $1.10B | $1.11B | $1.05B | $1.04B | $960.18M | $976.51M | $875.11M | $867.81M | $133.10M | $762.92M | $709.94M | $728.86M | $121.00M | $102.12M | $655.04M | $628.28M | $110.00M | $651.49M | $586.79M | $553.43M | $275.00M | $464.84M | $367.47M |
High Forecast | $1.29B | $1.23B | $1.24B | $1.15B | $1.32B | $1.24B | $1.21B | $1.15B | $1.16B | $1.10B | $1.08B | $975.18M | $991.53M | $876.11M | $868.88M | $159.72M | $777.88M | $724.72M | $761.27M | $145.20M | $122.55M | $655.04M | $628.28M | $132.00M | $651.49M | $586.79M | $553.43M | $330.00M | $464.84M | $367.47M |
Low Forecast | $1.18B | $1.12B | $1.14B | $1.05B | $1.20B | $1.13B | $1.11B | $1.05B | $1.06B | $1.00B | $990.91M | $930.18M | $961.49M | $874.12M | $866.74M | $106.48M | $747.95M | $695.15M | $695.54M | $96.80M | $81.70M | $655.04M | $628.28M | $88.00M | $651.49M | $586.79M | $553.43M | $220.00M | $464.84M | $367.47M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 2.60% | 1.37% | 0.27% | 0.41% | 1.00% | 0.15% | 0.71% | 0.34% | 1.24% | 0.45% | -0.42% |
Forecast
SG&A Forecast
Quarter
Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 5 | 8 | 5 | 5 | 10 | 7 | 5 | 5 | 8 | 5 | 4 | 11 | 16 | 8 | 5 | 10 | 11 | 23 | 13 | 12 | 19 | 18 | 17 | 16 | 11 | 11 | 11 | 22 | 11 | 8 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.22B | $1.16B | $1.13B | $1.17B | $1.06B | $1.15B | $1.07B | $1.12B | $1.02B | $1.03B | $984.00M |
Avg Forecast | $1.88B | $1.83B | $1.87B | $1.75B | $1.95B | $1.88B | $1.87B | $1.79B | $1.79B | $1.72B | $1.71B | $1.63B | $1.62B | $1.48B | $1.48B | $1.28B | $1.32B | $1.28B | $1.29B | $1.17B | $1.24B | $1.15B | $1.18B | $1.06B | $1.14B | $1.09B | $1.08B | $821.77M | $1.03B | $925.78M |
High Forecast | $1.95B | $1.89B | $1.93B | $1.81B | $2.02B | $1.94B | $1.93B | $1.85B | $1.86B | $1.78B | $1.77B | $1.69B | $1.65B | $1.49B | $1.48B | $1.54B | $1.33B | $1.29B | $1.33B | $1.40B | $1.49B | $1.15B | $1.18B | $1.27B | $1.14B | $1.09B | $1.08B | $986.13M | $1.03B | $925.78M |
Low Forecast | $1.81B | $1.77B | $1.80B | $1.69B | $1.88B | $1.81B | $1.80B | $1.73B | $1.73B | $1.66B | $1.65B | $1.58B | $1.60B | $1.48B | $1.48B | $1.03B | $1.31B | $1.26B | $1.24B | $932.80M | $991.58M | $1.15B | $1.18B | $848.00M | $1.14B | $1.09B | $1.08B | $657.42M | $1.03B | $925.78M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 1.04% | 0.94% | 0.98% | 0.99% | 1.00% | 1.01% | 0.98% | 1.04% | 1.24% | 0.99% | 1.06% |
Forecast
EPS Forecast
Quarter
Dec 27 | Sep 27 | Jun 27 | Mar 27 | Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 5 | 8 | 5 | 5 | 10 | 7 | 5 | 5 | 8 | 5 | 4 | 11 | 16 | 8 | 5 | 10 | 11 | 23 | 13 | 12 | 19 | 18 | 17 | 16 | 11 | 11 | 11 | 22 | 11 | 8 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $0.21 | $0.09 | $0.12 | $0.17 | $0.07 | $0.06 | $0.28 | $0.12 | $0.23 | $0.10 | $-0.12 |
Avg Forecast | $0.83 | $0.79 | $0.80 | $0.74 | $0.85 | $0.80 | $0.78 | $0.74 | $0.75 | $0.71 | $0.70 | $0.65 | $0.66 | $0.59 | $0.58 | $0.51 | $0.51 | $0.48 | $0.49 | $0.43 | $0.47 | $0.44 | $0.42 | $0.38 | $0.44 | $0.40 | $0.37 | $0.31 | $0.31 | $0.25 |
High Forecast | $0.87 | $0.83 | $0.84 | $0.77 | $0.88 | $0.83 | $0.81 | $0.77 | $0.78 | $0.74 | $0.73 | $0.66 | $0.67 | $0.59 | $0.58 | $0.51 | $0.52 | $0.49 | $0.51 | $0.45 | $0.49 | $0.44 | $0.42 | $0.38 | $0.44 | $0.40 | $0.37 | $0.31 | $0.31 | $0.25 |
Low Forecast | $0.79 | $0.75 | $0.76 | $0.71 | $0.81 | $0.76 | $0.74 | $0.71 | $0.72 | $0.67 | $0.67 | $0.63 | $0.65 | $0.59 | $0.58 | $0.51 | $0.50 | $0.47 | $0.47 | $0.41 | $0.45 | $0.44 | $0.42 | $0.38 | $0.44 | $0.40 | $0.37 | $0.31 | $0.31 | $0.25 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 0.49% | 0.19% | 0.27% | 0.40% | 0.18% | 0.14% | 0.71% | 0.32% | 0.75% | 0.32% | -0.48% |
Forecast
Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
DXCM | DexCom | $81.07 | $104.50 | 28.90% | Buy |
STE | STERIS | $204.12 | $262.50 | 28.60% | Buy |
MDT | Medtronic | $80.95 | $95.40 | 17.85% | Hold |
ZBH | Zimmer Biomet | $104.47 | $122.63 | 17.38% | Hold |
SYK | Stryker | $361.52 | $413.17 | 14.29% | Buy |
SNN | Smith & Nephew | $24.42 | $27.00 | 10.57% | Buy |
ABT | Abbott Laboratories | $113.83 | $120.09 | 5.50% | Buy |
BSX | Boston Scientific | $90.69 | $95.50 | 5.30% | Buy |
ZIMV | ZimVie | $13.99 | $14.50 | 3.65% | Buy |
EW | Edwards Lifesciences | $73.91 | $76.33 | 3.27% | Buy |